SCHEMBL6170426

SCHEMBL6170426

COc1cc(OC)c2cc(-c3ccccc3)c(=O)[nH]c2c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.71
MEN1 O00255 1/20 0.71
NPC1 O15118 1/20 0.71
RAB9A P51151 1/20 0.71
ATM Q13315 1/20 0.71
ALDH1A1 P00352 5/20 0.57
HPGD P15428 4/20 0.57
KDM4E B2RXH2 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
ABCG2 Q9UNQ0 1/20 0.52
METAP2 P50579 1/20 0.47
MAPT P10636 2/20 0.46
TP53 P04637 1/20 0.46
CYP3A4 P08684 1/20 0.46
THRB P10828 1/20 0.46
HSD17B10 Q99714 1/20 0.46
PDE3B Q13370 1/20 0.45
PDE3A Q14432 1/20 0.45
TUBB4A P04350 1/20 0.44
TUBB P07437 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6169412 0.90 RAB9A (0.57) KMT2AMEN1NPC1RAB9AATM
SCHEMBL6172194 0.86 MEN1 (0.53) KMT2AMEN1NPC1RAB9AATM
SCHEMBL6170924 0.86 MEN1 (0.54) KMT2AMEN1NPC1RAB9AATM
SCHEMBL6170246 0.83 KMT2A (0.50) KMT2AMEN1NPC1RAB9AATM
SCHEMBL6171096 0.80 MEN1 (0.46) KMT2AMEN1NPC1RAB9AATM
SCHEMBL8987358 0.77 ALDH1A1 (0.59) KMT2AMEN1NPC1RAB9AATM
SCHEMBL6808565 0.76 ALDH1A1 (0.65) KMT2AMEN1NPC1RAB9AATM
SCHEMBL31611895 0.75 NPC1 (0.63) KMT2AMEN1NPC1RAB9AATM
SCHEMBL7807602 0.75 MEN1 (0.68) KMT2AMEN1NPC1RAB9AATM
SCHEMBL8576483 0.75 MEN1 (0.49) KMT2AMEN1NPC1RAB9AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097138-B1 PHARMACEUTICAL COMPOSITIONS COMPRISING 2-QUINOLONES LAFON LABOR (FR) 2005-12-07 EP disclosed
CN-1195740-C Pharmaceutical composition containing 2-quinolinone LAFON LABOR (FR) 2005-04-06 CN disclosed
US-6593342-B1 Activity on the proliferation of clonogenic cells in tumours and comprising an efficient amount of a compound selected among the compounds LABORATOIRE L. LAFON (FR) 2003-07-15 US disclosed
CN-1309639-A Pharmaceutical composition containing 2-quinolinone LAFON LABOR (FR) 2001-08-22 CN disclosed
EP-1097138-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING 2-QUINOLONES LABORATOIRE L. LAFON (FR) 2001-05-09 EP disclosed
WO-2000003990-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING 2-QUINOLONES LABORATOIRE L. LAFON (FR) 2000-01-27 WO disclosed